![](/img/cover-not-exists.png)
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Jacobs, Maartje S., de Jong, Lisa A., Postma, Maarten J., Tieleman, Robert G., van Hulst, MarinusLanguage:
english
Journal:
The European Journal of Health Economics
DOI:
10.1007/s10198-017-0942-2
Date:
November, 2017
File:
PDF, 1.24 MB
english, 2017